'L’influence du droit canonique sur les précurseurs du droit international : Honorat Bové, Francisco de Vitoria, Richard Zouche', in: Der Einfluss der Kanonistik auf die Europäische Rechtskultur, Bd. 6: Völkerrecht (Norm und Struktur 37), O. Condorelli, F. Roumy, M. Schmoeckel (Hg.), Bölhau, Köln, 2020, pp. 316-331

Autor: Dounot, Cyrille

Publikováno v: Der Einfluss der Kanonistik auf die Europäische Rechtskultur, Bd. 6: Völkerrecht (Norm und Struktur 37), O. Condorelli, F. Roumy, M. Schmoeckel (Hg.), Bölhau, Köln, 2020, 392 p.
Böhlau Verlag. Der Einfluss der Kanonistik auf die Europäische Rechtskultur, Bd. 6: Völkerrecht (Norm und Struktur 37), O. Condorelli, F. Roumy, M. Schmoeckel (Hg.), Bölhau, Köln, 2020, 392 p., pp. 316-331, 2020, 978-3412518905

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7af11635638dfe9bafc4f6dfaea5cef6
https://hal.uca.fr/hal-02928405

Childhood pancreatic neuroendocrine neoplasms: A national experience.

Autor: Courtel T; Unité d'Onco-Hémato-Immunologie pédiatrique, CHU Angers, Angers, France., Orbach D; SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, Paris-Saclay University (PSL), Paris, France., Lacour B; French National Registry of Childhood Solid Tumors, CHU Nancy, Nancy, France.; Inserm UMR 1153, Centre of Research in Epidemiology and StatisticS (CRESS), Paris University, Epidemiology of Childhood and Adolescent Cancers Team (EPICEA), Paris, France., Roumy M; Plateforme de recherche clinique pédiatrique, CHU Angers, Angers, France., Hescot S; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Desandes E; French National Registry of Childhood Solid Tumors, CHU Nancy, Nancy, France.; Inserm UMR 1153, Centre of Research in Epidemiology and StatisticS (CRESS), Paris University, Epidemiology of Childhood and Adolescent Cancers Team (EPICEA), Paris, France., Philippe-Chomette P; Department of Pediatric Surgery, Assistance Publique des Hôpitaux de Paris, Hôpital Robert Debré, Paris, France., Sarnacki S; Department of Pediatric Surgery, Urology and Transplantation, Necker-Enfants Malades Hospital, APHP, Université de Paris Cité, Paris, France., Irtan S; APHP-Sorbonne University, Paris, France.; Department of Pediatric Visceral and Neonatal Surgery, Armand-Trousseau Children's Hospital, APHP, Paris, France., Dijoud F; Institut Multisite de Pathologie, CHU de Lyon, Lyon, France., Kubicek P; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers, France., Brisse H; Department of Imaging, Institut Curie, PSL University, Paris, France., Fresneau B; Gustave Roussy, Université Paris-Saclay, Department of Children and Adolescent Oncology, Paris-Saclay University, Paris-Sud University, CESP, INSERM, Villejuif, France., Pire A; Department of Pediatric Surgery, Urology and Transplantation, Necker-Enfants Malades Hospital, APHP, Université de Paris Cité, Paris, France., Réguerre Y; Unité d'oncologie et d'hématologie pédiatrique, CHU Saint Denis de la Réunion, Bellepierre, France., Mallebranche C; Unité d'Onco-Hémato-Immunologie pédiatrique, CHU Angers, Angers, France.; Université d'Angers, Université de Nantes, CHU Angers, INSERM, CRCI2NA, SFR ICAT, Angers, France.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2025 Feb; Vol. 72 (2), pp. e31258. Date of Electronic Publication: 2024 Aug 12.

Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study.

Autor: Berlanga P; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Ndounga-Diakou LA; Pharmacovigilance Unit, Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Aerts I; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL Research University, Paris, France., Corradini N; Paediatric Haematology-Oncology Institut, of Centre Léon Bérard, Lyon, France., Ducassou S; Paediatric Haematology-Oncology Department, Centre Hospitalier Universitaire (CHU), Bordeaux, France., Strullu M; Paediatric Immuno-Haematology Department, Hôpital Robert-Debré AP-HP, Paris, France., de Carli E; Department of Pediatric Oncology, University Hospital, Angers, France., André N; Department of Pediatric Hematology & Oncology, Hôpital de La Timone, AP-HM, Marseille, France., Entz-Werle N; Pediatric Onco-Hematology Unit, University Hospital of Strasbourg, Strasbourg, France., Raimbault S; Department of Pediatric Oncology, Oscar Lambret Cancer Center, Lille, France., Roumy M; Department of Pediatric Oncology, University Hospital, Angers, France., Renouard M; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL Research University, Paris, France., Gueguen G; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Plantaz D; Department of Pediatric Onco-Immuno-Hematology, Grenoble Alpes University Hospital, Grenoble, France., Reguerre Y; Pediatric Oncology and Hematology Unit, CHU Saint Denis de la Réunion, Bellepierre, France., Cleirec M; Pediatric Immuno-Hemato-Oncology Unit, CHU Nantes, Nantes, France., Petit A; Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Paris, France., Puiseux C; Department of Pediatric Hemato-Oncology, University Hospital of Rennes, Rennes, France., Andry L; Department of Pediatric Oncology, CHU Amiens Picardie, Amiens, France., Klein S; Pediatric Oncology and Hematology, CHU Jean-Minjoz, Besançon, France., Bodet D; Department of Pediatric Hematology and Oncology, University Hospital of Caen, Caen, France., Kanold J; Department of Pediatric Hematology-Oncology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France., Briandet C; Pediatric Oncology, CHU Dijon-Bourgogne, Dijon, France., Halfon-Domenech C; Department of Pediatric Hematology-Oncology, University Hospital of Lyon, Lyon, France., Nelken B; Department of Pediatric Hematology-Oncology, Jeanne de Flandre Hospital, CHRU, Lille, France., Piguet C; Pediatric Oncology, CHU Limoges, Limoges, France., Saumet L; Department of Pediatric Hematology-Oncology, University Hospital of Montpellier, Montpellier, France., Chastagner P; Department of Pediatric Hematology-Oncology, Children's Hospital of Brabois, Vandoeuvre Les Nancy, France., Benadiba J; Department of Hemato-Oncology Pediatric, Nice University Hospital, Nice, France., Millot F; Department of Paediatric Haematology and Oncology, Centre Hospitalo-Universitaire de Poitiers, Poitiers, France., Pluchart C; Department of Paediatric Haematology and Oncology, Centre Hospitalo-Universitaire de Reims, Reims, France., Schneider P; Department of Pediatric Hematology and Oncology, Centre Hospitalo-Universitaire de Rouen, Rouen, France., Thouvenin S; Department of Pediatric Hematology-Oncology, University Hospital St Etienne, St Etienne, France., Gambart M; Department of Pediatric Oncology, Toulouse University Hospital, Toulouse, France., Serre J; Department of Pediatric Hematology-Oncology, CHRU de Tours, Tours, France., Abbou S; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Leruste A; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL Research University, Paris, France., Cayzac H; Pharmacovigilance Unit, Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Gandemer V; Department of Pediatric Hemato-Oncology, University Hospital of Rennes, Rennes, France., Laghouati S; Pharmacovigilance Unit, Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Vassal G; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.

Publikováno v: JAMA network open [JAMA Netw Open] 2023 Jul 03; Vol. 6 (7), pp. e2321568. Date of Electronic Publication: 2023 Jul 03.

An Overview on Renal and Central Regulation of Blood Pressure by Neuropeptide FF and Its Receptors.

Autor: Lee, Hewang¹ (AUTHOR) jun.feranil@email.gwu.edu, Feranil, Jun B.¹ (AUTHOR) pjose01@gwu.edu, Jose, Pedro A.^1,2 (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 24, p13284. 17p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.